Original Article Cancer August 15, 2009
Therapeutic Effect of Recombinant Human Epidermal Growth Factor (RhEGF) on Mucositis in Patients Undergoing Radiotherapy, With or Without Chemotherapy, for Head And Neck Cancer
A Double-blind Placebo-controlled Prospective Phase 2 Multi-institutional Clinical Trial
This study was presented in a poster discussion at the 44th Annual Meeting of the American Society of Clinical oncology (ASCO), Chicago, Illinois, May 30-June 3, 2008
reference